Psoriasis Therapeutics - Global Market Outlook (2017-2026)

Psoriasis Therapeutics - Global Market Outlook (2017-2026)

  • Published: February 2018
  • ID: SMRC17020

According to Stratistics MRC, the Global Psoriasis Therapeutics market is expected to grow at a CAGR of 10.5% during the forecast period. Availability of new diagnostic procedures, growing preference for combination therapies, increasing awareness about treatment, rising demand for improved healthcare infrastructure and changing lifestyle of people are some factors influencing the market growth. Further, better diagnostic tools availablity for psoriasis will result in increasing the treatment-seeking patient population which in turn boost the market’s growth prospects in the coming years.

Psoriasis is a lifelong autoimmune disease characterized by patches of abnormal skin. It usually thought to be a genetic disease that is triggered by environmental factors. There is no cure for psoriasis however, a variety of treatments can assist control the symptoms. It varies in severity from small, localized patches to complete body coverage. These skin patches are usually red, itchy, and scaly. Living in moist humid climate appears to delay the condition for appearing. Dry arid climates seem to aggravate the condition. Washing with Psoriasis removes the dry skin, but then the skin underneath is raw. Hard water appears to worsen the condition in dry climates, but not as much in humid areas. Soft water appears better.

Depending on molecule, biologics segment dominated the market. This segment comprises medicinal products extracted from biological sources such as humans, animals, or microorganisms and manufactured biotechnologically using the latest technologies. Unlike synthesized drugs, they have a complex structure and are not easily identified or characterized. Biologics include products, such as enzymes, allergens, blood and blood components, gene therapy, recombinant proteins, somatic cells, tissues, and vaccines. The growth of this segment is also attributed to the launch of novel biologics like Cosentyx by Novartis. By geography, North America dominated the global market due to the established healthcare infrastructure, high adoption of therapeutics and presence of key manufacturers in the U.S are a few factors responsible for its large share. Moreover, increasing prevalence and favorable government initiatives are some drivers fueling the market growth.

Some of the key players in the global Psoriasis Therapeutics market Johnson & Johnson, Novartis AG, Merck & Co. Inc., Janssen Biotech Inc., Incyte Corp., Eli Lilly and Company, Eisai Co. Ltd., Celgene Corporation, Bristol Myers Squibb Co., AstraZeneca, Amgen, Inc., AbbVie Inc., LEO Pharma A/S, UCB S.A and  Pfizer Inc.

Dosage Forms Covered:
• Liquid
• Solid
• Semi-solid
• Molecule Covered:
• Small Molecules
• Biologics

Mechanism of Actions Covered:
• IL blocker
• PDE4 Inhibitors
• TNF Inhibitors
• Other Mechanism of Actions

Route of Administrations Covered:
• Topical
• Oral
• Parenteral

Distribution Channels Covered:
• Retail Pharmacy
• Online Sales
• Hospital Pharmacy
• Other Distribution Channels

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan       
    • China       
    • India       
    • Australia 
    • New Zealand     
    • South Korea      
    • Rest of Asia Pacific   
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary     
       
2 Preface  
    
 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints    
 3.4 Opportunities    
 3.5 Threats     
 3.6 Emerging Markets  
 3.7 Futuristic Market Scenario      
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes   
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Psoriasis Therapeutics Market, By Dosage Form  
 5.1 Introduction    
 5.2 Liquid     
 5.3 Solid     
 5.4 Semi-solid    
       
6 Global Psoriasis Therapeutics Market, By Molecule  
 6.1 Introduction    
 6.2 Small Molecules    
 6.3 Biologics     
       
7 Global Psoriasis Therapeutics Market, By Mechanism of Action
 7.1 Introduction    
 7.2 IL blocker     
 7.3 PDE4 Inhibitors    
 7.4 TNF Inhibitors    
 7.5 Other Mechanism of Actions   
       
8 Global Psoriasis Therapeutics Market, By Route of Administration

 8.1 Introduction    
 8.2 Topical     
 8.3 Oral     
 8.4 Parenteral    
       
9 Global Psoriasis Therapeutics Market, By Distribution Channel
 9.1 Introduction    
 9.2 Retail Pharmacy    
 9.3 Online Sales    
 9.4 Hospital Pharmacy    
 9.5 Other Distribution Channels   
       
10 Global Psoriasis Therapeutics Market, By Geography 

 10.1 Introduction    
 10.2 North America    
  10.2.1 US    
  10.2.2 Canada    
  10.2.3 Mexico    
 10.3 Europe     
  10.3.1 Germany    
  10.3.2 UK    
  10.3.3 Italy    
  10.3.4 France    
  10.3.5 Spain    
  10.3.6 Rest of Europe   
 10.4 Asia Pacific    
  10.4.1 Japan    
  10.4.2 China    
  10.4.3 India    
  10.4.4 Australia    
  10.4.5 New Zealand   
  10.4.6 South Korea   
  10.4.7 Rest of Asia Pacific   
 10.5 South America    
  10.5.1 Argentina   
  10.5.2 Brazil    
  10.5.3 Chile    
  10.5.4 Rest of South America  
 10.6 Middle East & Africa   
  10.6.1 Saudi Arabia   
  10.6.2 UAE    
  10.6.3 Qatar    
  10.6.4 South Africa   
  10.6.5 Rest of Middle East & Africa  
       
11 Key Developments     
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
 11.2 Acquisitions & Mergers   
 11.3 New Product Launch   
 11.4 Expansions    
 11.5 Other Key Strategies   
       
12 Company Profiling     
 12.1 Johnson & Johnson    
 12.2 Novartis AG    
 12.3 Merck & Co. Inc.    
 12.4 Janssen Biotech Inc.    
 12.5 Incyte Corp.    
 12.6 Eli Lilly and Company   
 12.7 Eisai Co. Ltd.    
 12.8 Celgene Corporation   
 12.9 Bristol Myers Squibb Co.   
 12.10 AstraZeneca    
 12.11 Amgen, Inc.    
 12.12 AbbVie Inc.    
 12.13 LEO Pharma A/S    
 12.14 UCB S.A     
 12.15 Pfizer Inc.    


List of Tables      
1 Global Psoriasis Therapeutics Market Outlook, By Region (2016-2026) (US$ MN)
2 Global Psoriasis Therapeutics Market Outlook, By Dosage Form  (2016-2026) (US$ MN)
3 Global Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
4 Global Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
5 Global Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
6 Global Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
7 Global Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
8 Global Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
9 Global Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
10 Global Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
11 Global Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
12 Global Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
13 Global Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
14 Global Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
15 Global Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
16 Global Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
17 Global Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
18 Global Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
19 Global Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
20 Global Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
21 Global Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
22 North America Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
23 North America Psoriasis Therapeutics Market Outlook, By Dosage Form  (2016-2026) (US$ MN)
24 North America Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
25 North America Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
26 North America Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
27 North America Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
28 North America Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
29 North America Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
30 North America Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
31 North America Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
32 North America Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
33 North America Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
34 North America Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
35 North America Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
36 North America Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
37 North America Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
38 North America Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
39 North America Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
40 North America Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
41 North America Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
42 North America Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
43 Europe Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
44 Europe Psoriasis Therapeutics Market Outlook, By Dosage Form  (2016-2026) (US$ MN)
45 Europe Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
46 Europe Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
47 Europe Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
48 Europe Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
49 Europe Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
50 Europe Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
51 Europe Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
52 Europe Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
53 Europe Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
54 Europe Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
55 Europe Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
56 Europe Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
57 Europe Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
58 Europe Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
59 Europe Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
60 Europe Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
61 Europe Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
62 Europe Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
63 Europe Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
64 Asia Pacific Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
65 Asia Pacific Psoriasis Therapeutics Market Outlook, By Dosage Form  (2016-2026) (US$ MN)
66 Asia Pacific Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
67 Asia Pacific Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
68 Asia Pacific Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
69 Asia Pacific Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
70 Asia Pacific Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
71 Asia Pacific Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
72 Asia Pacific Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
73 Asia Pacific Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
74 Asia Pacific Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
75 Asia Pacific Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
76 Asia Pacific Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
77 Asia Pacific Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
78 Asia Pacific Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
79 Asia Pacific Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
80 Asia Pacific Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
81 Asia Pacific Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
82 Asia Pacific Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
83 Asia Pacific Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
84 Asia Pacific Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
85 South America Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
86 South America Psoriasis Therapeutics Market Outlook, By Dosage Form  (2016-2026) (US$ MN)
87 South America Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
88 South America Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
89 South America Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
90 South America Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
91 South America Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
92 South America Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
93 South America Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
94 South America Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
95 South America Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
96 South America Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
97 South America Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
98 South America Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
99 South America Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
100 South America Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
101 South America Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
102 South America Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
103 South America Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
104 South America Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
105 South America Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)
106 Middle East Psoriasis Therapeutics Market Outlook, By Country (2016-2026) (US$ MN)
107 Middle East Psoriasis Therapeutics Market Outlook, By Dosage Form  (2016-2026) (US$ MN)
108 Middle East Psoriasis Therapeutics Market Outlook, By Solid (2016-2026) (US$ MN)
109 Middle East Psoriasis Therapeutics Market Outlook, By Semi-solid (2016-2026) (US$ MN)
110 Middle East Psoriasis Therapeutics Market Outlook, By Molecule (2016-2026) (US$ MN)
111 Middle East Psoriasis Therapeutics Market Outlook, By Small Molecules (2016-2026) (US$ MN)
112 Middle East Psoriasis Therapeutics Market Outlook, By Biologics (2016-2026) (US$ MN)
113 Middle East Psoriasis Therapeutics Market Outlook, By Mechanism of Action (2016-2026) (US$ MN)
114 Middle East Psoriasis Therapeutics Market Outlook, By IL blocker (2016-2026) (US$ MN)
115 Middle East Psoriasis Therapeutics Market Outlook, By PDE4 Inhibitors (2016-2026) (US$ MN)
116 Middle East Psoriasis Therapeutics Market Outlook, By TNF Inhibitors (2016-2026) (US$ MN)
117 Middle East Psoriasis Therapeutics Market Outlook, By Other Mechanism of Actions (2016-2026) (US$ MN)
118 Middle East Psoriasis Therapeutics Market Outlook, By Route of Administration (2016-2026) (US$ MN)
119 Middle East Psoriasis Therapeutics Market Outlook, By Topical (2016-2026) (US$ MN)
120 Middle East Psoriasis Therapeutics Market Outlook, By Oral (2016-2026) (US$ MN)
121 Middle East Psoriasis Therapeutics Market Outlook, By Parenteral (2016-2026) (US$ MN)
122 Middle East Psoriasis Therapeutics Market Outlook, By Distribution Channel (2016-2026) (US$ MN)
123 Middle East Psoriasis Therapeutics Market Outlook, By Retail Pharmacy (2016-2026) (US$ MN)
124 Middle East Psoriasis Therapeutics Market Outlook, By Online Sales (2016-2026) (US$ MN)
125 Middle East Psoriasis Therapeutics Market Outlook, By Hospital Pharmacy (2016-2026) (US$ MN)
126 Middle East Psoriasis Therapeutics Market Outlook, By Other Distribution Channels (2016-2026) (US$ MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials